Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-25 @ 12:26 PM
NCT ID:
NCT02394795
Pre Assignment Details:
Participants with KRAS/NRAS wild-type, incurable/unresectable, advanced/recurrent colorectal cancer were enrolled and randomized to either the mFOLFOX6 + panitumumab arm (Group P) or mFOLFOX6 + bevacizumab arm (Group B) at 1:1 ratio.
Recruitment Details:
Participants took part in the study at 197 investigative sites in Japan from 29 May 2015 to 14 January 2022.
Study:
NCT02394795
Study Brief:
Results Section:
NCT02394795